ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Susan Halabi

161 views

June 26, 2024

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

2024 ASCO® Annual Meeting Insights Hub: GU Videos

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Adv…

2024 ASCO® Annual Meeting Insights Hub

T. Stewart

11 views

1 month ago

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

606 views

3 months ago

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

365 views

4 months ago

View All

PROSCA 2024 - Hybrid Global Forum on GU Oncology

Thu, Nov 28, 2024

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.6K views

9 months ago

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views

8 months ago

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

7 months ago

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

11 months ago

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

Ana Aparicio

1.6K views

11 months ago

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

7 months ago

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

432 views

1 month ago

AUA Advanced Prostate Cancer Guidelines: 2023 Update

Robert Dreicer

1.3K views

11 months ago

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

606 views

3 months ago

Testosterone Suppression and Recovery in Patients With Advanced Pros…

Benjamin L. Maughan

661 views

5 months ago

ASCO® 2024 Summary: "Prostate Cancer Highlights"

2024 ASCO® Annual Meeting Insights Hub

N. Reizine, K. Tawagi

566 views

4 months ago

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

276 views

1 month ago

Precision Therapies for Prostate Cancer

University of Miami Sylvester Comprehensive Cancer Center

M. Bilusic

356 views

3 months ago

GnRH Agonists vs. Antagonists in Prostate Cancer

Patrick Campbell

318 views

2 months ago

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

2024 ASCO® Annual Meeting Insights Hub

J. Hafron

643 views

5 months ago

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

1.8K views

1 year ago

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

GRACE

K. Jatwani, K. Tawagi, M. Kurian

242 views

3 months ago

New

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

194 views

1 week ago

Updates in the Treatment and Management of Prostate Cancer

Integrity CE

S. Kadambi, B. Guercio, M. Galsky

143 views

3 months ago

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

533 views

4 months ago

AUTOPLAY

Login

Login

Join VuMedi

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Model for Predicting OS in Men With mCRPC Treated With Potent AR Inhibition (Alliance)"

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

2024 ASCO® Annual Meeting Insights Hub: GU Videos

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Adv…

ASCO® 2024 Prostate Cancer Take-Home Messages

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

Recommended

PROSCA 2024 - Hybrid Global Forum on GU Oncology

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Recent GU Developments and Their Clinical Implications

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Cancer Screening Molecular Tools

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

Hyperprogression in Cancer Treated With Immunotherapy

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

ASCO® 2024 Prostate Cancer Take-Home Messages

Testosterone Suppression and Recovery in Patients With Advanced Pros…

ASCO® 2024 Summary: "Prostate Cancer Highlights"

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

Precision Therapies for Prostate Cancer

GnRH Agonists vs. Antagonists in Prostate Cancer

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Updates in the Treatment and Management of Prostate Cancer

Developmental Therapeutics Highlights From ASCO® 2024